Biotech Archives - Page 678 of 795

2 minute read

Ainos Announces Results From Additional Preclinical Study Of Its Low-Dose Oral Interferon Formulation; Showed ‘showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period…

September 30, 7:04 AM

VELDONA® formulation showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period. By upregulation of immunomodulatory, Ainos'

AIMD

1 minute read

Zealand Pharma Announces Results From Phase 3 Trial Of Glepaglutide; Glepaglutide Treatment Met Primary Endpoint

By Benzinga Newsdesk

September 30, 6:17 AM

Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1) Glepaglutide treatment met the primary endpoint with twice weekly dosing achieving a

ZEAL

6 minute read

Rocket Pharmaceuticals Announces Updates From Phase 1 Clinical Trial For RP-A501

By Benzinga Newsdesk

September 30, 6:03 AM

— Pediatric efficacy data for both patients show initial improvements across clinical, functional and biomarker endpoints with six to nine months of follow-up; positive results including protein

RCKT

1 minute read

FDA
News

Amylyx Pharmaceuticals Receives FDA Approval Of Relyvrio For Treatment Of Amyotrophic Lateral Sclerosis

By Michael Horton

September 29, 4:38 PM

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216660

AMLX

3 minute read

Iridex Showcases Its Non-Incisional Treatments For Glaucoma, Introduces Sweep Management Software, And Hosts 8 Physician Presentations At AAO 2022

By Benzinga Newsdesk

September 29, 4:08 PM

MicroPulse® Transscleral Laser Therapy (TLT), continuous-wave transscleral cyclophotocoagulation (CW-TSCPC), and MicroPulse Laser Trabeculoplasty (MLT) are non-incisional treatments that expand ways to

IRIX

1 minute read

Immunovant’s New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say

By Vandana Singh

September 29, 2:36 PM

On Wednesday, Immunovant Inc (NASDAQ:IMVT) announced a new anti-FcRn, IMVT-1402, at Roivant Sciences Ltd’s (NASDAQ:ROIV) Investor Day. IMVT-1402 is a new anti-FcRn monoclonal antibody…

ARGX

1 minute read

SIGA Technologies Bags New DoD Contract For Monkeypox Treatment

By Vandana Singh

September 29, 1:35 PM

SIGA Technologies Inc (NASDAQ:SIGA) announced that the U.S. Department of Defense (DoD) awarded a new contract to the company…

SIGA

1 minute read

Novo Nordisk Joins NLRP3 Bandwagon, Bets $70M On Ventus’ Lead Drug Candidate

By Vandana Singh

September 29, 12:49 PM

Biotechnology startup Ventus Therapeutics is licensing its lead research program, a drug candidate for inflammatory disorders, to Novo Nordisk A/S (NYSE:NVO) for…

NVO

1 minute read

Biohaven’s ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months

By Vandana Singh

September 29, 12:24 PM

Biohaven Pharmaceutical Holding Company Ltd (NASDAQ: BHVN) announced results from a focused analysis of verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS).

BHVN